Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-18

Clinical Trial Update: Pemetrexed, Cisplatin With Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pemetrexed in combination with cisplatin for soft tissue sarcoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • CISPLATIN (cisplatin)

Snippet

Sponsor: Yonsei University | Conditions: Sarcoma,Soft Tissue | Phase 2 | Status: RECRUITING